Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Werfen is a global, private company dedicated to the development, manufacturing, and distribution of specialized in-vitro diagnostic (IVD) solutions for hospitals and clinical laboratories. With a strong focus on Hemostasis, Acute Care Diagnostics, and Autoimmunity, Werfen aims to improve patient care and efficiency in healthcare settings worldwide. The company is committed to innovation, quality, and providing clinicians with the tools they need for accurate and timely diagnoses.
Serves as the central hub for Werfen's global operations, including corporate strategy, global R&D oversight, financial management, and administrative functions.
Located in a modern business district, the headquarters likely features contemporary architecture and state-of-the-art facilities designed to foster collaboration and innovation. Plaza Europa is known for its modern buildings and strategic location.
The HQ work culture emphasizes innovation, scientific excellence, global collaboration, and a patient-centric approach. Werfen promotes a culture of continuous improvement and professional development for its employees.
The Barcelona headquarters is pivotal for coordinating Werfen's worldwide activities, driving its strategic vision, and maintaining its leadership in specialized diagnostics. It symbolizes the company's strong European roots and global reach.
Werfen operates directly in over 30 countries and through an extensive network of distributors in more than 100 countries worldwide. This global footprint enables comprehensive support for its specialized diagnostic solutions in Hemostasis, Acute Care Diagnostics, and Autoimmunity. Functions supported globally include research and development at multiple international sites, advanced manufacturing facilities, direct sales and marketing teams, localized customer service and technical support, and efficient logistics and distribution networks to ensure product availability for hospitals and clinical laboratories across the globe.
Plaza Europa 21-23
L'Hospitalet de Llobregat
Barcelona
Spain
Address: 180 Hartwell Road, Bedford, MA 01730, USA
Serves as the primary center for the North American market, driving technological advancements and providing comprehensive support for Werfen's product lines in the region.
Address: 10451 Pacific Center Ct, San Diego, CA 92121, USA
Leads Werfen's global efforts in the autoimmune diagnostics field, developing innovative tests for a wide range of autoimmune diseases and serving specialized laboratories worldwide.
Address: Werfen GmbH, Martin-Kollar-Str. 4, 81829 München, Germany
Ensures strong market presence and customer service in Central Europe, tailoring solutions and support to meet the specific needs of healthcare providers in this important region.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Werfen' leadership includes:
Werfen has been backed by several prominent investors over the years, including:
Based on publicly available information, no major C-suite level executive hires or exits at Werfen have been widely announced in the past 12 months. The company generally maintains a stable and long-term focused leadership team.
Discover the tools Werfen uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Werfen most commonly uses the email format combining an employee's first name and last name, separated by a dot, followed by '@werfen.com'. Other patterns like first initial followed by last name might exist but are less common.
firstname.lastname@werfen.com
Format
jane.doe@werfen.com
Example
90%
Success rate
Werfen Newsroom • Feb 27, 2024
Werfen announced its financial results for 2023, reporting revenue of 2.04 billion Euro, reflecting an organic growth of 7.2%. The company highlighted strong performance across its business lines, including Hemostasis, Acute Care Diagnostics, and Autoimmunity, and noted the positive impact of strategic initiatives and the integration of Immucor....more
Werfen Newsroom • Jan 8, 2024
Werfen received FDA 510(k) clearance for its Aptiva Celiac Disease IgA and IgG reagents. This clearance expands Werfen's autoimmune diagnostic offerings in the US, enabling automated and efficient testing for celiac disease on the Aptiva system....more
Werfen Newsroom • Nov 13, 2023
Werfen announced the successful completion of its acquisition of Immucor, Inc., a global leader in transfusion and transplant diagnostics. This strategic move significantly expands Werfen's portfolio into new clinical areas and strengthens its position as a global IVD leader....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Werfen, are just a search away.